Printer Friendly

Browse Postmenopausal women topic

Drug therapy subtopic

Articles

1-113 out of 113 article(s)
Title Author Type Date Words
Sermonix to collaborate with Eli Lilly to study lasofoxifene/abemaciclib combo. Jul 9, 2020 247
Swimming as Treatment for Osteoporosis: A Systematic Review and Meta-analysis. Su, Yanlin; Chen, Zhe; Xie, Wei Report May 31, 2020 5276
Association between Hypertension, Antihypertensive Drugs, and Osteoporosis in Postmenopausal Syrian Women: A Cross-Sectional Study. Hijazi, Nermeen; Alourfi, Zaynab Clinical report Mar 31, 2020 3496
Progestin-only systemic hormone therapy for menopausal hot flashes. Barbieri, Robert L. Feb 1, 2020 1457
Breast cancer risk 'drug of choice' HEALTH. JANE KIRBY Dec 13, 2019 120
Breast Cancer Drug Shows Long-Lasting Prevention Power. Dec 12, 2019 789
Role of Transobturator Tape in the Treatment of Mixed Urinary Incontinence in Women. R., Neelakandan; B., Jagadish Kaushik; T., Chandru; K., Natarajan Clinical report Dec 2, 2019 5025
Knight and TherapeuticsMD Announce Filing of New Drug Submission for Joyesta[TM] in Canada. Oct 30, 2019 1324
Amgen and UCB announce positive CHMP opinion for EVENITY programme for treatment of severe osteoporosis in postmenopausal women. Oct 18, 2019 282
Amgen and UCB announce positive CHMP opinion for EVENITY programme for treatment of severe osteoporosis in postmenopausal women. Oct 18, 2019 278
Medicinal Plants for the Treatment of Postmenopausl Osteoporosis. Sharon, S. Evelyn; Chitra, V. Sep 1, 2019 9250
The Effectiveness and Safety of Acupoint Catgut Embedding for the Treatment of Postmenopausal Osteoporosis: A Systematic Review and Meta-Analysis. Huang, Fan; Xie, Yumin; Zhao, Siyi; Feng, Zitong; Chen, Guizhen; Xu, Yunxiang Aug 31, 2019 10042
Sandoz enrols first patient in osteoporosis biosimilar drug trial. Jul 24, 2019 218
Sandoz enrols first patient in osteoporosis biosimilar drug trial. Jul 24, 2019 222
Evenity gets FDA approval for treating osteoporosis. Palmer, Christopher Jun 1, 2019 288
Amgen markets EVENITY in the US for the treatment of osteoporosis. Apr 16, 2019 273
Amgen markets EVENITY in the US for the treatment of osteoporosis. Apr 16, 2019 269
Amgen (NASDAQ: AMGN) - FDA Approves EVENITY[TM] (romosozumab-aqqg) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture -- 9/4/2019. Apr 16, 2019 1231
Amgen (NASDAQ: AMGN) - FDA Approves EVENITY[TM] (romosozumab-aqqg) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture -- 9/4/2019. Apr 11, 2019 1232
Amgen & UCB partnership wins US FDA approval for EVENITY (romosozumab-aqqg) to treat osteoporosis in postmenopausal women. Apr 10, 2019 297
Amgen & UCB partnership wins US FDA approval for EVENITY (romosozumab-aqqg) to treat osteoporosis in postmenopausal women. Apr 10, 2019 293
Amgen says FDA approves EVENITY for treatment of osteoporosis. Apr 9, 2019 229
FDA Grants First Approval for CA Drug Under New Pilot Programs; Ribociclib approved in combo with AI as endocrine tx for HR-positive, HER2-negative advanced breast CA. Jul 24, 2018 257
BREAST CANCER DRUG SNUB. Apr 24, 2018 316
FDA Approves Lilly's Verzenio (abemaciclib) as Initial Treatment for Advanced Breast Cancer. Mar 1, 2018 402
Osteoporosis treatment preferences and satisfaction in postmenopausal women: Denosumab compared with oral bisphosphonates. Baiger, Boguslawa Report Mar 1, 2018 5474
Lilly wins additional US FDA approval for Verzenio (abemaciclib) for treating advanced breast cancer. Feb 27, 2018 286
Lilly wins additional US FDA approval for Verzenio (abemaciclib) for treating advanced breast cancer. Feb 27, 2018 282
European Commission Approves Endoceutics' Drug IntrarosaTM for the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women. Jan 15, 2018 356
Amgen submits EVENITY's MAA with EMA for the treatment of osteoporosis in women and men. Jan 8, 2018 290
Amgen submits EVENITY's MAA with EMA for the treatment of osteoporosis in women and men. Jan 8, 2018 286
Arterial Stiffness in Breast Cancer Patients Treated with Anthracycline and Trastuzumab-Based Regimens. Yersal, Ozlem; Eryilmaz, Ufuk; Akdam, Hakan; Meydan, Nezih; Barutca, Sabri Jan 1, 2018 4072
Soy, broccoli may cut breast cancer treatment's side effects: Study. Clinical report Dec 13, 2017 277
Novartis receives EC authorisation for Kisqali (ribociclib) breast cancer drug. Aug 25, 2017 267
Novartis receives EC authorisation for Kisqali (ribociclib) breast cancer drug. Aug 25, 2017 263
FDA approves ribociclib for HR+, HER2- advanced breast cancer. Nikolaides, Laura Apr 1, 2017 412
Mylan unveils generic Aromasin Tablets for the treatment of breast cancer in women in the US. Mar 14, 2017 140
Mylan unveils generic Aromasin Tablets for the treatment of breast cancer in women in the US. Mar 14, 2017 136
The Tissue-Selective Estrogen Complex (Bazedoxifene/Conjugated Estrogens) for the Treatment of Menopause. Lello, Stefano; Capozzi, Anna; Scambia, Giovanni Report Jan 1, 2017 7403
Hormone therapy for memory......blood pressure variation......depression and dementia. Column Nov 1, 2016 622
Amgen & UCB submits Romosozumab's BLA to the US FDA for the treatment of osteoporosis in postmenopausal women. Jul 22, 2016 293
Amgen & UCB submits Romosozumab's BLA to the US FDA for the treatment of osteoporosis in postmenopausal women. Jul 22, 2016 289
New Market Research Report: Global Postmenopausal Osteoporosis Drugs Market 2016-2020. May 24, 2016 481
Pfizer files NDA of Palbociclib with US FDA for breast cancer. Aug 19, 2014 228
Pfizer files NDA of Palbociclib with US FDA for breast cancer. Aug 19, 2014 224
CPD: August 2014. Aug 1, 2014 632
Anti-malarial drug reverses resistance to breast cancer drug in mice: Study. Jun 14, 2014 133
Mylan unveils generic US FDA approved Actonel Tablets, 150 mg, for treating osteoporosis in postmenopausal women. Jun 12, 2014 141
Mylan unveils generic US FDA approved Actonel Tablets, 150 mg, for treating osteoporosis in postmenopausal women. Jun 12, 2014 137
The hormone estrogen may not boost women's mental abilities. Brief article Feb 1, 2014 128
Study on the role of zoledronic acid in treatment of postmenopausal osteoporosis. Clinical report Dec 31, 2013 2729
Breast cancer drug halves disease risk in post-menopausal women. Dec 13, 2013 370
Breast Cancer Drug Better than Tamoxifen Cuts Disease Risk by 50%. Dec 12, 2013 517
Pfizera[euro](tm)s DUAVEE receives FDA approval for treatment of moderate-to-severe vasomotor symptoms (hot flashes) associated with menopause and the prevention of postmenopausal osteoporosis. Oct 4, 2013 299
Drug 'Aromasin' prevents breast cancer. Jun 9, 2013 128
FDA approves a new oral drug for vulvar and vaginal atrophy. Jun 1, 2013 469
A simple, inexpensive solution for pain from breast cancer treatment. Mar 1, 2013 621
Novartisa[euro](tm) Afinitor approved by US FDA in advanced breast cancer. Jul 23, 2012 271
What older women should know about breast cancer treatment. May 1, 2012 502
What you should know about statin use after menopause: potential risks do not outweigh known benefits. Apr 1, 2012 639
Breast cancer prevention drug reduces BMD. Moon, Mary Ann Clinical report Feb 15, 2012 1083
Healing after breast cancer treatment. MacDonald, Barbara Feb 1, 2012 8856
Targeted therapies in breast cancer: tailoring treatment to the molecular drivers of disease progression. Hicks, David G. Report Jan 1, 2012 1909
NICE says no to AstraZeneca's breast cancer drug Faslodex. Dec 15, 2011 163
Drug combination may help hormone-resistant breast cancer. McBride, Deborah Brief article Dec 1, 2011 237
Exemestane for breast cancer prevention in post-menopausal women. Brief article Nov 1, 2011 284
Drug combo prolongs progression-free survival time in breast cancer. Sep 26, 2011 293
New agents for the treatment of osteoporosis/Osteoporozda yeni tedavi ajanlari. Guven, Zeynep; Celiker, Reyhan; Atalay, Ayce; Bagis, Selda Sep 1, 2011 6871
Breast cancer medication launched. Jun 6, 2011 176
FDA approves Warner Chilcott's ACTONEL for treatment of postmenopausal osteoporosis. Oct 11, 2010 101
New pathways in osteoporosis therapy: a preview of new agents. Cummings, Steven R. Oct 1, 2010 1429
AstraZeneca secures FDA approval for 500mg dose of FASLODEX Injection for metastatic breast cancer. Sep 13, 2010 169
Aromatase inhibitors and bone health. Bundred, Nigel J. Clinical report Jul 1, 2010 4209
Acupuncture could relieve joint pain linked to breast cancer treatments. Mar 5, 2010 411
The fixed herbal drug composition "Saikokaryukotsuboreito" prevents bone loss with an association of serum IL-6 reductions in ovariectomized mice model. Hattori, T.; Fei, W.; Kizawa, T.; Nishida, S.; Yoshikawa, H.; Kishida, Y. Report Mar 1, 2010 5189
Osteoporosis drug may help cut risk of bone fractures, breast cancer, stroke. Feb 25, 2010 395
Combo approved for breast cancer. Feb 15, 2010 177
Combo approved for breast cancer. Brief article Feb 15, 2010 177
GlaxoSmithKline announces accelerated approval for TYKERB for metastatic breast cancer. Feb 1, 2010 179
GlaxoSmithKline announces accelerated approval for TYKERB for metastatic breast cancer. Feb 1, 2010 153
FDA approves Tykerb for treatment of advanced breast cancer. Feb 1, 2010 261
AstraZeneca announces data from a Phase III study of fulvestrant in postmenopausal women. Dec 14, 2009 305
Myomin: natural aromatase inhibitor for estrogen-related conditions. Chi, Tsu-Tsair Report Dec 1, 2009 4809
Decrease in hormone therapy use may reduce breast cancer risk. Nov 9, 2009 352
Strontium ranelate for the treatment of post-menopausal osteoporosis / Postmenopozal osteoporoz tedavisinde stronsiyum ranelat. Bozbey, Ismahan; Yalcin, Ayse Peyman Report Sep 1, 2009 4702
Postmenopausal women on statins are less prone to AF. Boschert, Sherry Aug 1, 2008 445
Brittle-bone drug found to prevent breast cancer. Jun 11, 2008 254
New guidelines for osteoporosis prevention, Tx: the national osteoporosis foundation has expanded its guidelines beyond postmenopausal white women. Boschert, Sherry Jun 1, 2008 1091
Breast cancer drug breakthrough. Dec 15, 2007 469
Women at risk needed for cancer drug trials. Nov 14, 2007 435
Panel backs osteoporosis drug for reducing breast ca risk. Bullock, Lorinda Sep 1, 2007 495
Panel okays drug to lower breast ca risk. Bullock, Lorinda Aug 15, 2007 630
Panel okays drug to cut breast cancer risk in postmenopause. Bullock, Lorinda Aug 15, 2007 591
Study: osteoporosis drug benefits last beyond treatment. Mar 1, 2007 261
Switch to exemestane beneficial in early breast ca. Lowry, Fran Clinical report Aug 15, 2006 276
Don't stop bisphosphonates if benefit not apparent at first. Boschert, Sherry Feb 1, 2006 464
Bisphosphonates cut fractures but compliance is often poor. Splete, Heidi Jun 1, 2005 434
Assessment of urinary bone markers for monitoring treatment of osteoporosis. Worsfold, Michael; Powell, Diane E.; Jones, Teresa J.W.; Davie, Michael W.J. Clinical report Dec 1, 2004 6464
Think twice before prescribing HT for diabetic patients. Johnson, Kate Oct 1, 2004 461
Triglycerides do not alter raloxifene's lipid effects. Jancin, Bruce Sep 1, 2004 372
Tibolone increases bone density, lacks side effects: as effective as hormone therapy. Sullivan, Michele G. Jan 1, 2004 581
Zyrtec may cut postmenopausal hot flashes: small trial. Sullivan, Michele G. Brief Article Nov 1, 2003 223
Estrogen plus progestin may increase incidence of dementia. Culhane, Nicole S. Oct 1, 2003 779
All estrogen medications get a black box. (Hot Flashes). Brief Article Jan 1, 2003 372
Are less than standard doses of hormone replacement therapy (HRT) effective for the treatment of hot flushes? Andy, Camille Brief Article Sep 1, 2001 751
Raloxifene Causes No Increase in CV Events in Women. ZOLER, MITCHEL L. Brief Article May 1, 2001 380
HRT: Short-Term Solution for Menopasual Symptoms. BOSCHERT, SHERRY Brief Article Jan 15, 2000 516
Whites, Nonsmokers, Low Baseline HDL Get Best Lipid Response to HRT. JANCIN, BRUCE Jan 15, 2000 375
PRO & CON. Brief Article Aug 15, 1999 780
Influence of aromatase inhibitors on plasma total homocysteine in postmenopausal breast cancer patients. Anker, Gun B.; Refsum, Helga; Ueland, Per M.; Johannessen, Dag C.; Lien, Ernst A.; Lonning, Per E. Feb 1, 1999 3138
Weighing hormone therapy's benefits. Raloff, Janet Brief Article Jun 21, 1997 552
New drug staves off osteoporosis. Jun 24, 1995 625
Forever smart: does estrogen enhance memory? Fackelmann, Kathy Cover Story Feb 4, 1995 2072

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters